oxacillin has been researched along with ceftobiprole in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, G; Cuirolo, A; Faccone, D; Goldstein, F; Kitzis, MD; Ly, A; Morris, J; Perutka, J; Plata, K; Rosato, AE; Sournia, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Antignac, A; Chung, M; Kim, C; Tomasz, A | 1 |
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
| Bush, K; Davies, TA; Flamm, RK; Shang, W | 1 |
| Biedenbach, DJ; Deshpande, LM; Jones, RN; Mutnick, AH | 1 |
1 trial(s) available for oxacillin and ceftobiprole
| Article | Year |
|---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
6 other study(ies) available for oxacillin and ceftobiprole
| Article | Year |
|---|---|
Identification and phenotypic characterization of a beta-lactam-dependent, methicillin-resistant Staphylococcus aureus strain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cephalosporins; Chromosomes, Bacterial; DNA-Binding Proteins; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression Regulation, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Selection, Genetic; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Transcription, Genetic | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Effects of ceftobiprole and oxacillin on mecA expression in methicillin-resistant Staphylococcus aureus clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Gene Expression Regulation, Bacterial; Methicillin-Resistant Staphylococcus aureus; Oxacillin; Penicillin-Binding Proteins; Polymerase Chain Reaction | 2010 |
In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci.
Topics: Cephalosporins; Drug Evaluation, Preclinical; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus | 2002 |